These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 14531724)
21. The effect of food on plasma and tissue concentrations of linezolid after multiple doses. Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930 [TBL] [Abstract][Full Text] [Related]
22. Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects? Hamilton R; Thai XC; Ameri D; Pai MP J Antimicrob Chemother; 2013 Mar; 68(3):666-73. PubMed ID: 23160755 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis. Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837 [TBL] [Abstract][Full Text] [Related]
24. Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis. Hallam MJ; Allen JM; James SE; Donaldson PM; Davies JG; Hanlon GW; Dheansa BS J Burn Care Res; 2010; 31(1):207-9. PubMed ID: 20061858 [TBL] [Abstract][Full Text] [Related]
25. Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid. Bhamidipati R; Venkatesh P; Dravid PV; Narasimhulu PC; Tvrs S; Das J; Mullangi R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2005; 30(3):187-93. PubMed ID: 16250256 [TBL] [Abstract][Full Text] [Related]
26. Age and sex effects on the pharmacokinetics of linezolid. Sisson TL; Jungbluth GL; Hopkins NK Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis. Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775 [TBL] [Abstract][Full Text] [Related]
28. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers. Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669 [TBL] [Abstract][Full Text] [Related]
29. Ocular penetration of linezolid after oral administration in rabbits. Saleh M; Lefevre S; Bourcier T; Prevost G; Gaucher D; Speeg-Schatz C; Jehl F J Ocul Pharmacol Ther; 2011 Jun; 27(3):243-6. PubMed ID: 21510740 [TBL] [Abstract][Full Text] [Related]
30. Effect of severity of sepsis on tissue concentrations of linezolid. Thallinger C; Buerger C; Plock N; Kljucar S; Wuenscher S; Sauermann R; Kloft C; Joukhadar C J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976 [TBL] [Abstract][Full Text] [Related]
31. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532 [TBL] [Abstract][Full Text] [Related]
32. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880 [TBL] [Abstract][Full Text] [Related]
33. [Linezolid, an agent from a new class of antibiotics]. Kuijper EJ; Schippers EF; Bernards AT Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556 [TBL] [Abstract][Full Text] [Related]
34. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections. Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321 [TBL] [Abstract][Full Text] [Related]
35. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient. Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration. Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid. Humphrey SJ; Curry JT; Turman CN; Stryd RP J Cardiovasc Pharmacol; 2001 May; 37(5):548-63. PubMed ID: 11336106 [TBL] [Abstract][Full Text] [Related]
39. Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings. Beringer P; Nguyen M; Hoem N; Louie S; Gill M; Gurevitch M; Wong-Beringer A Antimicrob Agents Chemother; 2005 Sep; 49(9):3676-81. PubMed ID: 16127039 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients. Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]